同和药业
(300636)
| 流通市值：31.81亿 | | | 总市值：36.80亿 |
| 流通股本：3.64亿 | | | 总股本：4.22亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 132,148,876.62 | 421,145,881.9 | 534,774,791.43 | 512,753,422.59 |
| 应收票据及应收账款 | 106,289,452.65 | 108,454,027.05 | 118,735,203.7 | 70,771,939.06 |
| 应收账款 | 106,289,452.65 | 108,454,027.05 | 118,735,203.7 | 70,771,939.06 |
| 应收款项融资 | 3,556,921.31 | 98,353.95 | 9,510,794.18 | 98,988 |
| 预付款项 | 9,850,061.64 | 12,828,996.37 | 14,112,742.22 | 14,157,517.46 |
| 其他应收款合计 | 2,598,963 | 3,448,391.18 | 4,408,841.41 | 2,894,961.98 |
| 存货 | 561,229,478.14 | 526,060,357.7 | 494,396,038.27 | 523,416,724.31 |
| 一年内到期的非流动资产 | 175,808,618.2 | 153,086,845.96 | 74,859,886.8 | 49,652,222.21 |
| 其他流动资产 | 3,955,995.17 | 6,035,178.57 | 3,976,183.79 | 23,237,934.9 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 995,438,366.73 | 1,261,158,032.68 | 1,284,774,481.8 | 1,196,983,710.51 |
| 非流动资产: | | | | |
| 其他债权投资 | 769,390,590.57 | 525,730,562.81 | 564,586,956.64 | 488,842,238.78 |
| 长期股权投资 | 3,223,395.04 | 3,253,298.99 | 3,300,000 | - |
| 固定资产 | 1,328,414,924.76 | 1,351,288,668.88 | 980,778,301.71 | 1,008,211,108.35 |
| 在建工程 | 169,484,619.37 | 162,893,796.35 | 532,046,761.69 | 503,080,855.77 |
| 使用权资产 | 2,192,909.16 | 2,405,126.16 | 2,617,343.16 | 2,829,560.16 |
| 无形资产 | 19,483,916.03 | 19,711,520.93 | 19,939,125.83 | 20,166,730.73 |
| 递延所得税资产 | 140,372.78 | 284,837.5 | 288,001.09 | 231,975.78 |
| 其他非流动资产 | 7,315,752.44 | 3,308,030.9 | 2,537,867.9 | 1,093,558.91 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,299,646,480.15 | 2,068,875,842.52 | 2,106,094,358.02 | 2,024,456,028.48 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,295,084,846.88 | 3,330,033,875.2 | 3,390,868,839.82 | 3,221,439,738.99 |
| 流动负债: | | | | |
| 短期借款 | 329,428,036.67 | 433,656,146.21 | 449,531,253.77 | 429,312,470.41 |
| 应付票据及应付账款 | 143,246,596.11 | 107,939,707.77 | 104,682,126.21 | 130,393,252.94 |
| 其中：应付票据 | 82,294,855.66 | 44,892,034.76 | 68,725,245.92 | 81,558,584.22 |
| 应付账款 | 60,951,740.45 | 63,047,673.01 | 35,956,880.29 | 48,834,668.72 |
| 合同负债 | 5,658,642.4 | 2,998,165.35 | 3,390,836.95 | 2,087,288.19 |
| 应付职工薪酬 | 19,510,906.31 | 18,586,352.26 | 15,654,913.25 | 19,110,493.32 |
| 应交税费 | 1,670,477.91 | 1,942,573.18 | 1,450,607.21 | 1,668,327.16 |
| 其他应付款合计 | 18,937,738.4 | 16,043,307.14 | 29,039,752.12 | 31,530,191.23 |
| 一年内到期的非流动负债 | 17,928,640.13 | 17,928,640.13 | 68,392,781.42 | 87,609,124.92 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 536,381,037.93 | 599,094,892.04 | 672,142,270.93 | 701,711,148.17 |
| 非流动负债: | | | | |
| 长期借款 | 398,500,000 | 399,000,000 | 399,000,000 | 250,000,000 |
| 租赁负债 | 1,291,616.52 | 1,532,896.41 | 1,810,035.01 | 2,037,867.88 |
| 递延收益 | 3,894,782.36 | 3,938,508.62 | 3,978,484.88 | 4,018,461.14 |
| 递延所得税负债 | 45,651,943.88 | 44,503,759.76 | 42,490,987.36 | 37,223,137.53 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 449,338,342.76 | 448,975,164.79 | 447,279,507.25 | 293,279,466.55 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 985,719,380.69 | 1,048,070,056.83 | 1,119,421,778.18 | 994,990,614.72 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 421,527,350 | 421,527,350 | 423,136,145 | 423,136,145 |
| 资本公积 | 1,263,565,976.67 | 1,262,348,768.05 | 1,271,952,653.88 | 1,270,749,298.05 |
| 减:库存股 | 12,343,230.3 | 12,343,230.3 | 24,944,490.6 | 25,176,321 |
| 盈余公积 | 61,712,424.6 | 61,712,424.6 | 61,712,424.6 | 61,712,424.6 |
| 未分配利润 | 574,902,945.22 | 548,718,506.02 | 539,590,328.76 | 496,027,577.62 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,309,365,466.19 | 2,281,963,818.37 | 2,271,447,061.64 | 2,226,449,124.27 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,309,365,466.19 | 2,281,963,818.37 | 2,271,447,061.64 | 2,226,449,124.27 |
| 负债和股东权益合计 | 3,295,084,846.88 | 3,330,033,875.2 | 3,390,868,839.82 | 3,221,439,738.99 |
| 公告日期 | 2024-10-24 | 2024-08-29 | 2024-04-25 | 2024-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |